Literature DB >> 20691264

Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.

Sarah Willis1, James Stoll, Lawrence Sweetman, Karin Borges.   

Abstract

We hypothesized that in epileptic brains citric acid cycle intermediate levels may be deficient leading to hyperexcitability. Anaplerosis is the metabolic refilling of deficient metabolites. Our goal was to determine the anticonvulsant effects of feeding triheptanoin, the triglyceride of anaplerotic heptanoate. CF1 mice were fed 0-35% calories from triheptanoin. Body weights and dietary intake were similar in mice fed triheptanoin vs. standard diet. Triheptanoin feeding increased blood propionyl-carnitine levels, signifying its metabolism. 35%, but not 20%, triheptanoin delayed development of corneal kindled seizures. After pilocarpine-induced status epilepticus (SE), triheptanoin feeding increased the pentylenetetrazole tonic seizure threshold during the chronically epileptic stage. Mice in the chronically epileptic stage showed various changes in brain metabolite levels, including a reduction in malate. Triheptanoin feeding largely restored a reduction in propionyl-CoA levels and increased methylmalonyl-CoA levels in SE mice. In summary, triheptanoin was anticonvulsant in two chronic mouse models and increased levels of anaplerotic precursor metabolites in epileptic mouse brains. The mechanisms of triheptanoin's effects and its efficacy in humans suffering from epilepsy remain to be determined.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691264      PMCID: PMC2955820          DOI: 10.1016/j.nbd.2010.07.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  39 in total

1.  Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet.

Authors:  Kristopher J Bough; Jonathon Wetherington; Bjørnar Hassel; Jean Francois Pare; Jeremy W Gawryluk; James G Greene; Renee Shaw; Yoland Smith; Jonathan D Geiger; Raymond J Dingledine
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

Review 2.  Discovery of antiepileptic drugs.

Authors:  Misty Smith; Karen S Wilcox; H Steve White
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats.

Authors:  Claudia Brandt; Anna Heile; Heidrun Potschka; Thomas Stoehr; Wolfgang Löscher
Journal:  Epilepsia       Date:  2006-11       Impact factor: 5.864

4.  2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure.

Authors:  Mireia Garriga-Canut; Barry Schoenike; Romena Qazi; Karen Bergendahl; Timothy J Daley; Rebecca M Pfender; John F Morrison; Jeffrey Ockuly; Carl Stafstrom; Thomas Sutula; Avtar Roopra
Journal:  Nat Neurosci       Date:  2006-10-15       Impact factor: 24.884

5.  Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats.

Authors:  Renée P Kinman; Takhar Kasumov; Kathryn A Jobbins; Katherine R Thomas; Jillian E Adams; Lisa N Brunengraber; Gerd Kutz; Wolf-Ulrich Brewer; Charles R Roe; Henri Brunengraber
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-05-16       Impact factor: 4.310

6.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial.

Authors:  Elizabeth G Neal; Hannah Chaffe; Ruby H Schwartz; Margaret S Lawson; Nicole Edwards; Geogianna Fitzsimmons; Andrea Whitney; J Helen Cross
Journal:  Lancet Neurol       Date:  2008-05-02       Impact factor: 44.182

7.  Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats.

Authors:  Marcela de Almeida Rabello Oliveira; Terezinha da Rocha Ataíde; Suzana Lima de Oliveira; Ana Luíza de Melo Lucena; Carla Emmanuela Pereira Rodrigues de Lira; Anderson Acioli Soares; Clarissa Beatriz Santos de Almeida; Adriana Ximenes-da-Silva
Journal:  Neurosci Lett       Date:  2008-01-19       Impact factor: 3.046

8.  Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats.

Authors:  Xiao-Yuan Lian; Firdous A Khan; Janet L Stringer
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

Review 9.  Neurometabolism in human epilepsy.

Authors:  Jullie W Pan; Anne Williamson; Idil Cavus; Hoby P Hetherington; Hitten Zaveri; Ognen A C Petroff; Dennis D Spencer
Journal:  Epilepsia       Date:  2008       Impact factor: 5.864

Review 10.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

View more
  34 in total

1.  Triheptanoin improves brain energy metabolism in patients with Huntington disease.

Authors:  Isaac Mawusi Adanyeguh; Daisy Rinaldi; Pierre-Gilles Henry; Samantha Caillet; Romain Valabregue; Alexandra Durr; Fanny Mochel
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

2.  Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome.

Authors:  Pierangelo Veggiotti; Valentina De Giorgis
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

3.  Triheptanoin alters [U-13C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling by normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model.

Authors:  Tanya McDonald; Mark P Hodson; Ilya Bederman; Michelle Puchowicz; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-19       Impact factor: 6.200

Review 4.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

5.  Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function.

Authors:  Kah Ni Tan; Catalina Carrasco-Pozo; Tanya S McDonald; Michelle Puchowicz; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 6.  Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.

Authors:  Mussie Ghezu Hadera; Tanya McDonald; Olav B Smeland; Tore W Meisingset; Haytham Eloqayli; Saied Jaradat; Karin Borges; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2015-10-03       Impact factor: 3.996

Review 7.  Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns.

Authors:  Mary C McKenna; Susanna Scafidi; Courtney L Robertson
Journal:  Neurochem Res       Date:  2015-07-07       Impact factor: 3.996

8.  Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease.

Authors:  Jeremy S Francis; Vladimir Markov; Paola Leone
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

9.  Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice.

Authors:  Olav B Smeland; Mussie G Hadera; Tanya S McDonald; Ursula Sonnewald; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

10.  Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.

Authors:  Isaac Marin-Valencia; Levi B Good; Qian Ma; Craig R Malloy; Juan M Pascual
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.